Local Institution
Saint-Jérôme, Quebec J7Z 5T3
0 studies enrolling now · 7 studies all time
What they study most
Acute Coronary Syndrome, Acute Coronary Syndromes, Atrial Fibrillation, Metabolics Diabetes Nos, Non-small Cell Lung Cancer, Venous Thrombosis
Studies at this site
- A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart — Completed
- A Phase III Study of Apixaban in Patients With Atrial Fibrillation — Completed
- Phase III Acute Coronary Syndrome — Stopped early
- Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism — Completed
- Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism — Completed
- PPAR-COMBO With Sulfonylurea — Completed
- Study of BMS-275183 in Patients With Pretreated Locally Advanced or Metastatic NSCLC (Non Small Cell Lung Cancer) — Stopped early